Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease

被引:45
|
作者
Phillips, Jeffrey S. [1 ]
Das, Sandhitsu R. [2 ]
McMillan, Corey T. [1 ]
Irwin, David J. [1 ]
Roll, Emily E. [1 ]
Da Re, Fulvio [1 ,3 ,4 ]
Nasrallah, Ilya M. [5 ]
Wolk, David A. [6 ]
Grossman, Murray [1 ]
机构
[1] Univ Penn, Penn Frontotemporal Degenerat Ctr, Dept Neurol, 3400 Spruce St,2 Gibson, Philadelphia, PA 19104 USA
[2] Univ Penn, Penn Image Comp & Sci Lab, Philadelphia, PA 19104 USA
[3] Univ Milano Bicocca, Neurosci, Milan, Italy
[4] Univ Milano Bicocca, Milan Ctr Neurosci NeuroMI, Sch Med & Surg, Milan, Italy
[5] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA
[6] Univ Penn, Dept Neurol, Penn Memory Ctr, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
Alzheimer disease; cognition; dementia; language; memory; neurofibrillary tangles; primary progressive aphasia; positron emission tomography; posterior cortical atrophy; Tau; POSTERIOR CORTICAL ATROPHY; PARTIAL VOLUME CORRECTION; PRIMARY PROGRESSIVE APHASIA; EMISSION-TOMOGRAPHY TRACER; NEUROFIBRILLARY TANGLES; LOGOPENIC VARIANT; BETA ACCUMULATION; PATHOLOGY; LANGUAGE; ASSOCIATION;
D O I
10.1002/hbm.23874
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Accumulation of paired helical filament tau contributes to neurodegeneration in Alzheimer's disease (AD). F-18-flortaucipir is a positron emission tomography (PET) radioligand sensitive to tau in AD, but its clinical utility will depend in part on its ability to predict cognitive symptoms in diverse dementia phenotypes associated with selective, regional uptake. We examined associations between 18F-flortaucipir and cognition in 14 mildly-impaired patients (12 with cerebrospinal fluid analytes consistent with AD pathology) who had amnestic (n = 5) and non-amnestic AD syndromes, including posterior cortical atrophy (PCA, n = 5) and logopenic-variant primary progressive aphasia (lvPPA, n = 4). Amnestic AD patients had deficits in memory; lvPPA in language; and both amnestic AD and PCA patients in visuospatial function. Associations with cognition were tested using sparse regression and compared to associations in anatomical regions-of-interest (ROIs). F-18-flortaucipir uptake was expected to show regionally-specific correlations with each domain. In multivariate analyses, uptake was elevated in neocortical areas specifically associated with amnestic and non-amnestic syndromes. Uptake in left anterior superior temporal gyrus accounted for 67% of the variance in language performance. Uptake in right lingual gyrus predicted 85% of the variance in visuospatial performance. Memory was predicted by uptake in right fusiform gyrus and cuneus as well as a cluster comprising right anterior hippocampus and amygdala; this eigenvector explained 57% of the variance in patients' scores. These results provide converging evidence for associations between F-18-flortaucipir uptake, tau pathology, and patients' cognitive symptoms.
引用
收藏
页码:691 / 708
页数:18
相关论文
共 50 条
  • [1] Tau PET Imaging Predicts Cognition in Atypical Variants of Alzheimer's Disease
    Phillips, Jeffrey
    Das, Sandhitsu
    McMillan, Corey
    Irwin, David
    Nasrallah, Ilya
    Wolk, David
    Grossman, Murray
    [J]. NEUROLOGY, 2017, 88
  • [2] Distinct tau PET imaging patterns in typical and atypical Alzheimer's disease
    Sarazin, Marie
    Lagarde, Julien
    Bottlaender, Michel
    [J]. BRAIN, 2016, 139 : 1321 - 1324
  • [3] Tau PET Imaging in Alzheimer's Disease
    Okamura, Nobuyuki
    Harada, Ryuichi
    Furumoto, Shozo
    Arai, Hiroyuki
    Yanai, Kazuhiko
    Kudo, Yukitsuka
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2014, 14 (11)
  • [4] Tau PET Imaging in Alzheimer’s Disease
    Nobuyuki Okamura
    Ryuichi Harada
    Shozo Furumoto
    Hiroyuki Arai
    Kazuhiko Yanai
    Yukitsuka Kudo
    [J]. Current Neurology and Neuroscience Reports, 2014, 14
  • [5] IN VIVO TAU IMAGING WITH PET IN ALZHEIMER'S DISEASE
    Villemagne, V. L.
    Furumoto, S.
    Fodero-Tavoletti, M.
    Mulligan, R.
    Young, K.
    Kudo, Y.
    Masters, C. L.
    Yanai, K.
    Rowe, C. C.
    Okamura, N.
    [J]. INTERNAL MEDICINE JOURNAL, 2012, 42 : 32 - 33
  • [6] Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease
    Brier, Matthew R.
    Gordon, Brian
    Friedrichsen, Karl
    McCarthy, John
    Stern, Ari
    Christensen, Jon
    Owen, Christopher
    Aldea, Patricia
    Su, Yi
    Hassenstab, Jason
    Cairns, Nigel J.
    Holtzman, David M.
    Fagan, Anne M.
    Morris, John C.
    Benzinger, Tammie L. S.
    Ances, Beau M.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (338)
  • [7] PET imaging of tau pathology in Alzheimer's disease and tauopathies
    James, Olga G.
    Doraiswamy, P. Murali
    Borges-Neto, Salvador
    [J]. FRONTIERS IN NEUROLOGY, 2015, 6
  • [8] Alzheimer's disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline
    Bucci, Marco
    Chiotis, Konstantinos
    Nordberg, Agneta
    [J]. MOLECULAR PSYCHIATRY, 2021, 26 (10) : 5888 - 5898
  • [9] Alzheimer’s disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline
    Marco Bucci
    Konstantinos Chiotis
    Agneta Nordberg
    [J]. Molecular Psychiatry, 2021, 26 : 5888 - 5898
  • [10] Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease
    Sintini, Irene
    Martin, Peter R.
    Graff-Radford, Jonathan
    Senjem, Matthew L.
    Schwarz, Christopher G.
    Machulda, Mary M.
    Spychalla, Anthony J.
    Drubach, Daniel A.
    Knopman, David S.
    Petersen, Ronald C.
    Lowe, Val J.
    Jack, Clifford R., Jr.
    Josephs, Keith A.
    Whitwell, Jennifer L.
    [J]. NEUROIMAGE-CLINICAL, 2019, 23